Medical News

RSS

Hospira launches two-gram vial of gemcitabine hydrochloride for injection

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has launched a two-gram vial of gemcitabine hydrochloride for injection.

16 Nov 2010

Misonix to introduce OsteoSculpt for facial bone surgery at EACMFS Congress

Misonix, Inc., a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, has announced its attendance and exhibition at the 20th Congress of the European Association for Cranial-Maxillofacial Surgery (EACMFS), which was held recently in Bruges, Belgium.

16 Nov 2010

Pathfinder initiates Explorer clinical study for open liver procedures

Pathfinder Therapeutics, Inc. has initiated a clinical study to assess the value of Explorer, its image-guided surgical platform, in minimally invasive liver resections and ablations.

16 Nov 2010

New stem cell-infused patch improves heart function after myocardial infarction

University of Cincinnati (UC) researchers have found that applying a stem cell-infused patch together with overexpression of a specific cell instruction molecule promoted cell migration to damaged cardiac tissue following heart attack and resulted in improved function in animal models.

16 Nov 2010

District Court judgment favors Otsuka in Abilify patent litigation

Otsuka Pharmaceutical Co., Ltd. and Otsuka Holdings, Co., Ltd., the parent company of Otsuka Pharmaceutical Co., Ltd., announced today that the U.S. District Court for the District of New Jersey issued its judgment dated November 15, 2010 in favor of Otsuka Pharmaceutical Co., Ltd. in its patent litigation against several companies seeking FDA approval to market generic copies of Abilify.

16 Nov 2010

Sonova 2010/11 first half sales increases 17.2% to CHF 832 million

Sonova generated a new sales record of CHF 832 million in the first half of 2010/11, an increase of 17.2% in Swiss francs compared to the previous year.

16 Nov 2010

Researchers develop human cell-based model of Rett syndrome

A groundbreaking study published Friday in the leading scientific journal, Cell, revealed that a team of investigators had successfully generated nerve cells using skin cells from four individuals with Rett syndrome. The study, funded in part by IRSF, was led by Dr. Alysson Muotri at the University of California, San Diego--a leading researcher in the stem cell field.

16 Nov 2010

4SC to present development of resminostat and preclinical drug candidates at EORTC-NCI-AACR symposium

4SC, a drug discovery and development company focused on autoimmune and cancer indications, today announced that it will present four posters and respective abstracts that highlight the development of its lead oncology compound resminostat and several preclinical drug candidates at the 22nd EORTC-NCI-AACR symposium from 16 - 19 November, 2010 in Berlin, Germany.

16 Nov 2010

Employees will see changes in 2011 health benefits

"Workers who have received their annual enrollment packets for insurance benefits" should expect slight changes to their plans this year due to the health care overhaul. Most employees can expect to pay more next year, due in part to the 1 to 2 percent increase in insurance costs brought about by the law.

16 Nov 2010

As Congress heads into lame-duck, repeal of 1099 reporting provision likely

Heading into a lame-duck session, "Congress has several other items left on its docket. … there's a rewrite of the 1099 tax reporting requirements under the health care bill, which presently require businesses to report every expense over $600.

16 Nov 2010

Study finds two-thirds of asthma patients take combined ICS/LABA treatment

Despite national guidelines recommending that inhaled corticosteroid (ICS) be used alone as the preferred treatment for patients with mild persistent asthma, a new study finds that nearly two-thirds of these patients are taking more costly drugs that combine an ICS and a long-acting beta agonist (LABA) with no apparent additional clinical benefit noted based on pharmacy and medical claims.

16 Nov 2010

Medicare open enrollment period starts today

Coming changes to Medicare will benefit some recipients but will make coverage more expensive for people with higher incomes. Thanks in part to this year's health care overhaul, everything from benefits and enrollment rules to the number of choices available will be affected beginning Jan. 1.

16 Nov 2010

Merrion prepares Phase III study for Orazol in breast cancer treatment

After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.

16 Nov 2010

OncoEMR certified as Complete EHR by CCHIT

Altos Solutions, Inc. today announced that OncoEMR Version 2.6 is the first oncology-specific electronic medical record (EMR) to be certified as 2011/2012 compliant and was certified as a Complete EHR on November 11, 2010 by the Certification Commission for Health Information Technology (CCHIT), an ONC-ATCB, in accordance with the applicable eligible provider certification criteria adopted by the Secretary of Health and Human Services.

16 Nov 2010

Iron in plaque may predict risk of myocardial infarction

Plaque in a heart artery looks threatening, but cardiologists know that many of these buildups will not erupt, dislodge and block a vessel, causing a heart attack that can be fatal. Some will, however, and the challenge is to figure out atherosclerotic plaque that is dangerous and treat or remove it.

16 Nov 2010

Inconsistent food labels contribute to consumer uncertainty about appropriate food intake

People are easily fooled when it comes to food labels, and will eat more of something if they believe it's a "small" portion, according to a new study in the Journal of Consumer Research.

16 Nov 2010

Study finds significant variability in CPR quality between day and night

CPR quality is worse during in-hospital cardiac arrests occurring overnight than those that happen during the day, according to a new University of Pennsylvania School of Medicine study that will be presented at the American Heart Association's annual Scientific Sessions on November 14.

16 Nov 2010

IFPA announces winner of Under the Spotlight Award for psoriasis documentary

125 million people worldwide suffer from psoriasis and the hardships this difficult disease brings. Today, on the International Day of Tolerance we are very proud to announce the winner of the 1st Under the Spotlight Award for Best International Documentary on Psoriasis.

16 Nov 2010

Canadian government announces new research initiative on childhood obesity

The Honourable Leona Aglukkaq, Minister of Health, today announced new initiatives for research on physical activity and childhood obesity through the Canadian Institutes of Health Research (CIHR).

16 Nov 2010

National campaign to highlight significance of antibiotic resistance

Antibiotic resistance is one of the world's most pressing public health threats. To bring attention to this increasing problem, the Centers for Disease Control and Prevention and other government partners will observe its third annual Get Smart About Antibiotics Week on Nov. 15-21, 2010.

16 Nov 2010